tiprankstipranks
Medite Cancer Diagnostics Inc (MDIT)
OTHER OTC:MDIT
US Market
Holding MDIT?
Track your performance easily

Medite Cancer Diagnostics (MDIT) Financial Statements

5 Followers

Medite Cancer Diagnostics Financial Overview

Medite Cancer Diagnostics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Medite Cancer Diagnostics is scheduled to report earnings on August 14, 2017, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 18Jun 18Mar 18Dec 17Sep 17
Income Statement-
Total Revenue$ 2.39M$ 2.27M$ 1.50M$ 1.96M$ 1.69M
Gross Profit$ 1.47M$ 1.06M$ 335.00K$ -936.00K$ 369.00K
EBIT$ -78.00K$ -19.00K$ -960.00K$ -2.76M$ -1.41M
EBITDA$ -16.00K$ 49.00K$ -889.00K$ -2.68M$ -1.29M
Net Income Common Stockholders$ -757.00K$ -586.00K$ -1.43M$ -2.65M$ -1.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.00K$ 47.00K$ 153.00K$ 73.00K$ 1.65M
Total Assets$ 17.65M$ 16.61M$ 16.41M$ 15.96M$ 19.03M
Total Debt$ 6.05M$ 5.77M$ 5.56M$ 5.29M$ 5.01M
Net Debt$ 5.96M$ 5.72M$ 5.41M$ 5.22M$ 3.35M
Total Liabilities$ 11.21M$ 10.50M$ 10.46M$ 10.18M$ 11.01M
Stockholders Equity$ 6.44M$ 6.10M$ 5.94M$ 5.78M$ 8.02M
Cash Flow-
Free Cash Flow$ -832.00K$ -1.02M$ -1.64M$ -1.80M$ -479.00K
Operating Cash Flow$ -821.00K$ -1.01M$ -1.64M$ -1.71M$ -463.00K
Investing Cash Flow$ -11.00K$ -2.00K$ -2.00K$ -91.00K$ -16.00K
Financing Cash Flow$ 899.00K$ 887.00K$ 1.43M$ -591.00K$ 2.38M
Currency in USD

Medite Cancer Diagnostics Earnings and Revenue History

Medite Cancer Diagnostics Debt to Assets

Medite Cancer Diagnostics Cash Flow

Medite Cancer Diagnostics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis